1 |
Sung, T. S., Jeon, J. P., Kim, B. J., Hong, C., Kim, S. Y., Kim, J., Jeon, J. H., Kim, H. J., Suh, C. K., Kim, S. J. and So, I. 2011. Molecular determinants of PKA-dependent inhibition of TRPC5 channel. Am. J. Physiol. Cell Physiol. 301, C823-C832.
DOI
|
2 |
Thomas, S. G. 2000. Irritable bowel syndrome and mirtazapine. Am. J. Psychiatry 157, 1341-1342.
DOI
|
3 |
Hirst, G. D. S., Garcia-Londono, A. P. and Edwards, F. R. 2006. Propagation of slow waves in the Guinea-pig gastric antrum. J. Physiol. 571, 165-177.
DOI
|
4 |
Jung, H. Y., Lee, S. I., Kim, D. H. and Choi, E. J. 2004. A case of restless leg syndrome induced by mirtazapine in a patient with major depressive disorder. Clin. Psychopharmacol. Neurosci. 15, 488-491.
|
5 |
Huizinga, J. D., Chang, G., Diamant, N. E. and El-Sharkawy, T. Y. 1984. Electrophysiological basis of excitation of canine colonic circular muscle by cholinergic agents and substance P. J. Pharmacol. Exp. Ther. 231, 692-699.
|
6 |
Huizinga, J. D., Thuneberg, L., Kluppel, M. and Malysz, H. B. 1995. The W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature 373, 347-349.
DOI
|
7 |
Inoue, R. and Chen, S. 1993. Physiology of muscarinic receptor-operated nonselective cation channels in guinea-pig ileal smooth muscle. EXS. 66, 261-268.
|
8 |
Kim, B. J., Lim, H. H., Yang, D. K., Jun, J. Y., Chang, I. Y., Park, C. S., So, I., Stanfield, P. R. and Kim, K. W. 2005. Melastatin-type transient receptor potential channel 7 is required for intestinal pacemaking activity. Gastroenterology 129, 1504-1517.
DOI
|
9 |
Kim, S. W., Shin, I. S., Kim, J. M., Kang, H. C., Mun, J. U., Yang, S. J. and Yoon, J. S. 2006. Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment. Psychosomatics 47, 440-442.
DOI
|
10 |
Koh, S. D., Sanders, K. M. and Ward, S. M. 1998. Spontaneous electrical rhythmicity in cultured interstitial cells of Cajal from the murine small intestine. J. Physiol. 513, 203-213.
DOI
|
11 |
Huizinga, J. D. and Faussone-Pellegrini, M. S. 2005. About the presence of interstitial cells of Cajal outside the musculature of the gastrointestinal tract. J. Cell. Mol. Med. 9, 468-473.
DOI
|
12 |
Epperson, A., Hatton, W. J., Callaghan, B., Doherty, P., Walker, R. L., Sanders, K. M., Ward, S. M. and Horowitz, B. 2000. Molecular markers expressed in cultured and freshly isolated interstitial cells of Cajal. Am. J. Physiol. Cell Physiol. 279, C529-C539.
DOI
|
13 |
Gooden, J. Y. and Takahashi, P. Y. 2013. Mirtazapine treatment of diabetic gastroparesis as a novel method to reduce tube-feed residual: a case report. J. Med. Case Rep. 7, 38.
DOI
|
14 |
Hanani, M., Farrugia, G. and Komuro, T. 2005. Intercellular coupling of interstitial cells of Cajal in the digestive tract. Int. Rev. Cytol. 242, 249-282.
|
15 |
Timmer, C. J., Sitsen, J. M. and Delbressine, L. P. 2000. Clinical pharmacokinetics of mirtazapine. Clin. Pharmacokinet. 38, 461-474.
DOI
|
16 |
Yin, J., Wang, W., Winston, J. H., Zhang, R. and Chen, J. D. 2010. Ameliorating effects of mirtazapine on visceral hypersensitivity in rats with neonatal colon sensitivity. Neurogastroenterol. Motil. 22, 1022-1028.
DOI
|
17 |
Zhu, M. H., Kim, T. W., Ro, S., Yan, W., Ward, S. M., Koh, S. D. and Sanders, K. M. 2009. A Ca2+-activated Cl-conductance in interstitial cells of Cajal linked to slow wave currents and pacemaker activity. J. Physiol. 587, 4905-4918.
DOI
|
18 |
Koh, S. D., Ward, S. M., Ordog, T., Sanders, K. M. and Horowitz, B. 2003. Conductances responsible for slow wave generation and propagation in interstitial cells of Cajal. Curr. Opin. Pharmacol. 3, 579-582.
DOI
|
19 |
Fawcett, J. and Barkin, R. L. 1998. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression. J. Affect. Disord. 51, 267-285.
DOI
|
20 |
Halpert, A., Dalton, C. B., Diamant, N. E., Toner, B. B., Hu, Y., Morris, C. B., Bangdiwala, S. I., Whitehead, W. E. and Drossman, D. A. 2005. Clinical response to tricyclic antidepressants in functional bowel disorders is not related to dosage. Am. J. Gastroenterol. 100, 664-671.
DOI
|
21 |
O'Grady, G., Wang, T. H. H., Du, P., Angeli, T., Lammers, W. J. and Cheng, L. K. 2014. Recent progress in gastric arrhythmia: Pathophysiology, clinical significance and future horizons. Clin. Exp. Pharmacol. Physiol. 41, 854-862.
DOI
|
22 |
Yin, J., Song, J., Lei, Y., Xu, X. and Chen, J. D. Z. 2014. Prokinetic effects of mirtazapine on gastrointestinal transit. Am. J. Physiol. Gastrointest. Liver Physiol. 306, G796-G801.
DOI
|
23 |
Lang, R. J., Tonta, M. A., Zoltkowski, B. Z., Meeker, W. F., Wendt, I. and Parkington, H. C. 2006. Pyeloureteric peristalsis: Role of atypical smooth muscle cells and interstitial cells of Cajal-like cells as pacemakers. J. Physiol. 576, 695-705.
DOI
|
24 |
Lee, K. P., Jun, J. Y., Chang, I. Y., Suh, S. H., So, I. and Kim, K. W. 2005. TRPC4 is an essential component of the nonselective cation channel activated by muscarinic stimulation in mouse visceral smooth muscle cells. Mol. Cells 20, 435-441.
|
25 |
Liu, H. N., Ohya, S., Nishizawa, Y., Sawamura, K., Iino, S., Syed, M. M., Goto, K., Imaizumi, Y. and Nakayama, S. 2011. Serotonin augments gut pacemaker activity via 5-HT3 receptors. PLoS One 6, e24928.
DOI
|
26 |
Ogata, R., Inoue, Y., Nakano, H., Ito, Y. and Kitamura, K. 1996. Oestradiol-induced relaxation of rabbit basilar artery by inhibition of voltage-dependent Ca channels through GTP-binding protein. Br. J. Pharmacol. 117, 351-359.
DOI
|
27 |
Sanders, K. M., Koh, S. D., Ro, S. and Ward, S. M. 2012. Regulation of gastrointestinal motility--insights from smooth muscle biology. Nat. Rev. Gastroenterol. Hepatol. 9, 633-645.
DOI
|
28 |
Sener, M. T., Sener, E., Tok, A., Polat, B., Cinar, I., Polat, H., Akcay, F. and Suleyman, H. 2012. Biochemical and histologic study of lethal cisplatin nephrotoxicity prevention by mirtazapine. Pharmacol. Rep. 64, 594-602.
DOI
|
29 |
Lee, H. T., Hennig, G. W., Park, K. J., Bayguinov, P. O., Ward, S. M., Sanders, K. M. and Smith, T. K. 2009. Heterogeneities in ICC Ca2+ activity within canine large intestine. Gastroenterology 136, 2226-2236.
DOI
|
30 |
Kim, B. J., So, I. and Kim, K. W. 2006. The relationship of TRP channels to the pacemaker activity of interstitial cells of Cajal in the gastrointestinal tract. J. Smooth Muscle Res. 42, 1-7.
DOI
|
31 |
Shuman, M., Chukwu, A., Veldhuizen, N. V. and Miller, S. A. 2019. Relationship between mirtazapine dose and incidence of adrenergic side effects: An exploratory analysis. Ment. Health Clin. 9, 41-47.
DOI
|
32 |
Camilleri, M. and Chang, L. 2008. Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles. Gastroenterology 135, 1877-1891.
DOI
|
33 |
Choung, R. S., Cremonini, F., Thapa, P., Zinsmeister, A. R. and Talley, N. J. 2008. The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial. Neurogastroenterol. Motil. 20, 220-227.
DOI
|
34 |
de Boer, T. H., Nefkens, F., Van Helvoirt, A. and Van Delft, A. M. 1996. Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan. J. Pharmacol. Exp. Ther. 277, 852-860.
|
35 |
Demiryilmaz, I., Uzkeser, H., Cetin, N., Hacimuftuoglu, A., Bakan, E. and Altuner, D. 2013. Effect of mirtazapine on gastric oxidative stress and DNA injury created with methotrexate in rats. Asian J. Chem. 25, 2047.
DOI
|
36 |
Shahi, P. K., Choi, S., Zuo, D. C., Yeum, C. H., Yoon, P. J., Lee, J., Kim, Y. D., Park, C. G., Kim, M. Y., Shin, H. R., Oh, H. J. and Jun, J. Y. 2011. 5-hydroxytryptamine generates tonic inward currents on pacemaker activity of interstitial cells of cajal from mouse small intestine. Kor. J. Physiol. Pharmacol. 15, 129-135.
DOI
|
37 |
Tan, E., Smith, C. H. and Goldman, R. D. 2013. Antidepressants for functional gastrointestinal disorders in children. Can. Fam. Physician. 59, 263-264.
|
38 |
El-Tanbouly, D. M., Wadie, W. and Sayed, R. H. 2017. Modulation of TGF-β/Smad and ERK signaling pathways mediates the anti-fibrotic effect of mirtazapine in mice. Toxicol. Appl. Pharmacol. 329, 224-230.
DOI
|
39 |
Ford, A. C., Talley, N. J., Schoenfeld, P. S., Quigley, E. M. and Moayyedi, P. 2009. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 58, 367-378.
DOI
|
40 |
Grover, M., Farrugia, G., Lurken, M. S., Bernard, C. E., Faussone-Pellegrini, M. S., Smyrk, T. C. and NIDDK Gastroparesis Clinical Research Consortium. 2011. Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology 140, 1575-1585.
DOI
|
41 |
Sperber, A. D., Bangdiwala, S. I., Drossman, D. A., Ghoshal, U. C., Simren, M., Tack, J., Whitehead, W. E., Dumitrascu, D. L., Fang, X., Fukudo, S., Kellow, J., Okeke, E., Quigley, E. M. M., Schmulson, M., Whorwell, P., Archampong, T., Adibi, P., Andresen, V., Benninga, M. A., Bonaz, B., Bor, S., Fernandez, L. B., Choi, S. C., Corazziari, E. S., Francisconi, C., Hani, A., Lazebnik, L., Lee, Y. Y., Mulak, A., Rahman, M. M., Santos, J., Setshedi, M., Syam, A. F., Vanner, S., Wong, R. K., Lopez-Colombo, A., Costa, V., Dickman, R., Kanazawa, M., Keshteli, A. H., Khatun, R., Maleki, I., Poitras, P., Pratap, N., Stefanyuk, O., Thomson, S., Zeevenhooven, J. and Palsson, O. S. 2021. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome foundation global study. Gastroenterology 160, 99-114.
DOI
|